• Citer

Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

par Rogiers, Anne ;Leys, Christophe ;De Cremer, J.;Awada, Gil;Schembri, Adrian;Theuns, Peter;De Ridder, Mark;Neyns, Bart
Référence Supportive care in cancer, 28, page (3267-3278)
Publication Publié, 2020-12-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study
Auteur:	Rogiers, Anne; Leys, Christophe; De Cremer, J.; Awada, Gil; Schembri, Adrian; Theuns, Peter; De Ridder, Mark; Neyns, Bart
Informations sur la publication:	Supportive care in cancer, 28, page (3267-3278)
Statut de publication:	Publié, 2020-12-01
Sujet CREF:	Cancérologie
Mots-clés:	Cancer survivorship
	Immunotherapy
	Melanoma
	Pembrolizumab
	Psychosocial outcome
	Quality of life
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0941-4355
	info:doi/10.1007/s00520-019-05168-3
	info:scp/85075397259
	info:pmid/31745697